Indonesia
may allow private sector to buy and distribute vaccines
Send a link to a friend
[January 14, 2021]
By Maikel Jefriando and Stanley Widianto
JAKARTA (Reuters) - Indonesia may allow
companies to procure their own COVID-19 vaccines, the country's health
minister said on Thursday, as an influential business chamber called for
members to be able to inoculate staff or sell vaccines to the public.
|
The Southeast Asian country launched a mass immunisation campaign
targeting more than 180 million people this week to help tackle one
of the worst coronavirus outbreaks in Asia.
Medical and security personnel are first in line for the vaccine,
but Health Minister Budi Gunadi Sadikin told parliament companies
may be allowed to procure and vaccinate their staff and thereby
reduce the burden on the state.
"It shouldn't start now, but later after the government has provided
mandatory vaccines for health and public workers," he said, noting
no final decision had been made and that authorities wanted to avoid
being seen as prioritising the rich.

Indonesia currently buys and distributes vaccines for free at an
estimated cost of about $5.3 billion.
The head of Indonesia's business chamber told Reuters it had
requested that some companies be allowed to import approved vaccines
or buy government supplies to immunize staff or for sale.
"It's like going to the Disneyland ... if you want to go faster,
there's a priority pass, but you must pay more," Rosan Roeslani
said, adding businesses had already established links with vaccine
producers such as Russia's Sputnik V as well as others approved by
the World Health Organization.
[to top of second column] |
 He denied it was a privilege
for the rich since the cost per injection could
be below the current price for a private
COVID-19 swab test. Jahja
Setiaatmadja, chief executive of one of Indonesia's biggest lenders,
Bank Central Asia, said if the plan was approved the bank would like
to procure vaccines for staff.
Marsha Dyas, a 30-year-old Jakarta resident, also welcomed the idea
being able to buy a specific vaccine from a provider.But Andreas
Harsono, Indonesia researcher for Human Rights Watch, warned a
"private vaccination programme will create the risk that the poorest
and most vulnerable in the outer islands will be trampled in the
stampede for vaccines."
($1 = 14,050.0000 rupiah)
(Additional reporting by Tabita Diela; Writing and reporting by
Gayatri Suroyo; Editing by Ed Davies)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content
 |